Patent · US Active

Fumarate analogs and uses thereof

US9801866B2 · kind B2 · utility

2Cited by
3References
27Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 19, 2016
Grant dateOct 31, 2017
Priority date
Expiry dateSep 19, 2036

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Aspects of the present disclosure include compounds that find use for the treatment of a variety of autoimmune and inflammatory diseases and disorders. Embodiments of the present disclosure also relate to pharmaceutical compositions that include these compounds, methods of using these compounds in the treatment of various diseases and disorders, processes for preparing these compounds and intermediates useful in these processes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.